Yakira Capital Management’s abrdn Life Sciences Investors HQL Stock Holding History

Yakira Capital Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,500	Closed	-$187K	–	157
2020 Q1	$187K	Buy	+12,500	New	+$205K	0.06%	107
2014 Q4	–	Sell	-152,790	Closed	-$3.38M	–	103
2014 Q3	$3.38M	Sell	152,790 -148,088	-49%	-$3.22M	2.52%	15
2014 Q2	$6.25M	Buy	+300,878	New	+$6.32M	4.73%	4

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Yakira Capital Management's HQL Position: Q2 2020 in Review

Yakira Capital Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2020, closing a stake of 12,500 shares — an estimated $187K sold.

Yakira Capital Management first reported a position in HQL in Q2 2014 and held it in 3 quarters. The position peaked at $6.25M in Q2 2014. 70 funds tracked by Wall St. Rank hold HQL as of Q2 2020.

Yakira Capital Management reported no remaining abrdn Life Sciences Investors position as of Q2 2020 after selling out during the quarter.
Yakira Capital Management sold 12,500 abrdn Life Sciences Investors shares in Q2 2020, an estimated $187K.
Yakira Capital Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 3 quarters.
Yakira Capital Management's abrdn Life Sciences Investors position peaked at $6.25M in Q2 2014.
70 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2020.

Based on Yakira Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.